0001867096-24-000034.txt : 20240314
0001867096-24-000034.hdr.sgml : 20240314
20240314210341
ACCESSION NUMBER: 0001867096-24-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schmid John P.
CENTRAL INDEX KEY: 0001478916
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40880
FILM NUMBER: 24752237
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xeris Biopharma Holdings, Inc.
CENTRAL INDEX KEY: 0001867096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 871082097
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1375 WEST FULTON STREET, SUITE 1300
CITY: CHICAGO
STATE: IL
ZIP: 60607
BUSINESS PHONE: 844-445-5704
MAIL ADDRESS:
STREET 1: 1375 WEST FULTON STREET, SUITE 1300
CITY: CHICAGO
STATE: IL
ZIP: 60607
4
1
wk-form4_1710464612.xml
FORM 4
X0508
4
2024-03-14
0
0001867096
Xeris Biopharma Holdings, Inc.
XERS
0001478916
Schmid John P.
C/O XERIS BIOPHARMA HOLDINGS, INC.
1375 WEST FULTON STREET, SUITE 1300
CHICAGO
IL
60607
1
0
0
0
0
Common Stock
63159
D
Common Stock
2024-03-14
4
P
0
4500
2.16
A
11000
I
By: The Schmid Family Trust dated August 15, 2017
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Beth Hecht, as Attorney-in-Fact
2024-03-14